Pay-(FDA)-Per-(Pre)View of DTC

Last November, I posted information about AstraZeneca's proposal that the FDA review ALL DTC (direct-to-consumer) ads prior to running them (see "AstraZeneca's Risky Proposition").AZ called for "a mandatory requirement for pharmaceutical...

Kindler, Cheney: Kindred Spirits?

Peter Rost -- a true thorn in Pfizer's side -- and friends at Cafe Pharma have a little blog discussion going on regarding a Pfizer SEC filing, which states: "Mr. Kindler...

Caduet, Smaduet! Add some wood to the fire!

In an effort to stave off "Looming Brand Extinction," many drug companies are developing dual action drugs that combine a best-selling drug near patent extinction with another drug. Merck's Vytorin, which...

Marketing plan A for Plan B

Now that Plan B is approved for sale OTC and by prescription, Barr Pharmaceuticals is faced with the task of marketing it. What's their marketing "plan A" for Plan B?A few...

Market Research: Privacy Matters

This week I shared my experience as a subject in a Levitra/Men's Facts research project (see "My Sojourn as Market Research Subject for Levitra" and "Levitra Market Research: The Interview"). This...

Levitra Market Research: The Interview

On Monday, I posted the first part of my sojourn as a market research subject for Levitra (see "My Sojourn as Market Research Subject for Levitra"). This is the conclusion of...

My Sojourn as Market Research Subject for Levitra

Part 1: Why Was I Chosen?A few months ago, in response to a TV ad, I registered on www.mensfacts.com to receive a Men's Facts Kit and free sample offer for Levitra,...

Highlights & Updates

The following list of topics is a sampling of posts made to Pharma Marketing Blog in the past month or so. Some additional information has been added to bring some of...

Precision Buzz Marketing

Pharma companies have long ago mastered the art and science of "Precision Marketing" to physicians. No where has this prowess been demonstrated more conclusively than in a recent analysis of internal...

WLF: A No-Risk Ad is a Good Ad

According to a recent story in BrandWeek, "The Washington Legal Foundation, a conservative think tank, filed a petition with the Food and Drug Administration Monday , challenging the FDA's right to...

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -